News

The Office of the Chief Scientist (OCS) has approved this second-year grant to support Modigene’s hGH-CTP program for the period September 2008 through August 2009. The grant will

The acquired assets include all of Cyberkinetics’s rights and regulatory filings for the Andara Oscillating Field Stimulator (OFS) technology for treatment of acute spinal cord injury, an investigational

The new formulation is an immediate-release tablet that combines omeprazole, a proton pump inhibitor, with a mix of buffers. The new drug application (NDA) was submitted under section

The recommendation specifies the use of Revlimid, in combination with dexamethasone, as an option for the treatment of patients with multiple myeloma who have received two or more

Under the terms of the agreement, the two companies will collaborate on customized marketing promotions to MedAssets’s customers. The LifeSync wireless ECG system offers patient safety and productivity

Certain transitional activities will be continued at the facility for the next few weeks to ensure proper and compliant closure of the facility, however as of January 31,

The collaboration between Novartis and Gen-Probe was established in 1998. It was previously scheduled to expire in 2013. Under the original terms of the agreement, the companies shared

Upon investigational new drug and investigational medicinal product dossier clearance by the regulatory authorities, Pluristem plans to initiate clinical trials in Europe and in the US, administering PLX-PAD

These funds will enable Arcxis to accelerate development, testing, and commercialization of their innovative nucleic acid sample preparation platform and their next generation sample to answer clinical molecular